reports
Lexicon Pharmaceuticals Reports First Quarter 2024 Financial Results a...
Lexicon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update Commercial launch of INPEFA® (sotagliflozin) for Heart Failure continues to progress Resubmission of NDA for ZYNQUISTA™ (sotagliflozin) in Type 1 Diabetes expected mid-year 2024 Start-up ongoing for Phase 3 study of sotagliflozin in Hypertrophic Cardiomyopathy, with enrollment expected to begin mid-year 2024 Enrollment in Phase 2b PROGRESS study of LX9211 in Diabetic Peripheral Neuropathic Pain on track for expected Q2 2025 topline data Conference Call and Webcast at 5:00 pm Eastern Time ...
Lonnel Coats Retires as Chief Executive Officer and Board Member of Le...
Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon Pharmaceuticals THE WOODLANDS, Texas, April 29, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced that Lonnel Coats has provided notice of his retirement as chief executive officer and as a member of its board of directors, in each case effective July 7, 2024, his 10th anniversary with the company. The board of directors has initiated a search for a new chief executive officer which will consider both internal and external candidates. “During Mr. Coats’ tenure, Lexicon advanced two compounds through clin...
Lexicon Pharmaceuticals to Host First Quarter 2024 Financial Results C...
Lexicon Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 2, 2024 THE WOODLANDS, Texas, April 29, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) will release its first quarter 2024 financial results on Thursday, May 2, 2024 after the markets close. Management will conduct a conference call and live webcast at 5:00 p.m. ET (4:00 p.m. CT) that day to discuss the financial results and to provide a business update. Dial-in InformationU.S. Dial-in Number: (888) 317-6003International Dial-in Number: (412) 317-6061Conference ID: 5993982 Replay Informatio...
CORRECTING and REPLACING Expro Group Holdings N.V. Announces First Qua...
HOUSTON--(BUSINESS WIRE)-- Sixth paragraph, last sentence of the release should read: Second quarter revenue is expected to reflect approximately 3% year-on-year growth and sequential growth of 7%, with Adjusted EBITDA Margin in an expected range of 20% to 21%, or up 200 to 300 basis points year-on-year and sequentially in both cases based on the mid-point of second quarter guidance (instead of Second quarter revenue is expected to reflect approximately 20% year-on-year growth and sequential growth of 8%, with Adjusted EBITDA Margin in an expected range of 20% to 21%, or up 200 to 300 basis po...
Standard BioTools Announces Operational Restructuring Plan to Drive Lo...
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025Management to discuss first quarter 2024 financial results, restructuring and strategic initiatives on May 8, 2024 conference call SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it has initiated a restructuring plan to improve operational efficiency and reduce operating costs, while sup...
Standard BioTools Announces Conference Call and Webcast for First Quar...
Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024 SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the close of the market. The Company’s management will host a conference call and webcast at 1:30 p.m. PT, 4:30 p.m. ET, on May 8, 2024, to discuss first quarter 2024 financial results and operational progress. A press release including...
Capital Southwest Announces Fourth Quarter and Fiscal Year 2024 Earnin...
Capital Southwest Announces Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call Schedule Call Scheduled for 11:00 a.m. Eastern Time on Wednesday, May 15, 2024 DALLAS, April 24, 2024 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (“Capital Southwest” or the “Company”; Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, announced today that it will release its fourth quarter and fiscal year 2024 results on Tuesday, May 14, 2024, after t...
Greene County Bancorp, Inc. Reports Net Income of $18.0 million for th...
Greene County Bancorp, Inc. Reports Net Income of $18.0 million for the Nine Months Ended March 31, 2024 and opens Capital Region Banking Center in Albany, New York CATSKILL, N.Y., April 23, 2024 (GLOBE NEWSWIRE) -- Greene County Bancorp, Inc. (the “Company”) (NASDAQ: GCBC), the holding company for The Bank of Greene County and its subsidiary Greene County Commercial Bank, today reported net income for the three and nine months ended March 31, 2024, which is the third quarter of the Company’s fiscal year ending June 30, 2024. Net income for the three and nine months ended March 31, 2024 w...
Lexicon Pharmaceuticals to Host 2024 Investor Day
Lexicon Pharmaceuticals to Host 2024 Investor Day Includes Business and Scientific Updates from Lexicon Executives and Leading Medical Experts in Hypertrophic Cardiomyopathy, Type 1 Diabetes and Diabetic Peripheral Neuropathic Pain THE WOODLANDS, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced that senior company executives will be joined by leading physicians at the Lexicon 2024 Investor Day on April 22, 2024. The event will be held in New York City from 9:00 a.m. to 12:00 p.m. ET. Business and scientific updates will be presented by Lonnel Coats, Lexicon’s c...
Greene County Bancorp, Inc. Announces Cash Dividend
Greene County Bancorp, Inc. Announces Cash Dividend CATSKILL, N.Y., April 17, 2024 (GLOBE NEWSWIRE) -- Greene County Bancorp, Inc. (NASDAQ-GCBC) today announced that its Board of Directors has approved a quarterly cash dividend of $0.08 per share on the Company’s common stock. The dividend reflects an annual cash dividend rate of $0.32 per share which is the same rate as the dividend declared during the previous quarter. The cash dividend for the quarter ended March 31, 2024 will be paid to shareholders of record as of May 15, 2024, and is expected to be paid on May 30, 2024. The Compan...
Expro Group Holdings N.V. Schedules First Quarter 2024 Earnings Releas...
HOUSTON--(BUSINESS WIRE)-- Expro Group Holdings N.V. (NYSE: XPRO) (“Expro” or the “Company”) will hold a conference call on April 25, 2024 to discuss results for the quarter ended March 31, 2024. The conference call is scheduled to begin at 9:00 a.m. Central Time (10:00 a.m. Eastern Time). A press release regarding the results will be issued before the market opens on April 25 and the press release, together with associated presentation slides, will be posted to the investor relations section of the Expro website in advance of the conference call. We encourage those who plan to dial-in to th...
Standard BioTools Introduces New High-Throughput Multiplexed Whole Sli...
Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging New advancements, including automation, aim to fast-forward spatial biology SOUTH SAN FRANCISCO, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced the introduction of new solutions that add automation and flexibility to the Imaging Mass Cytometry™ workflow on the Hyperion XTi™ Imaging System. Spatial biology is...
Expro Report Highlights Progress Unlocking Energy Answers of Tomorrow
HOUSTON--(BUSINESS WIRE)-- Expro (NYSE: XPRO), a leading provider of energy services, has published its latest sustainability report, highlighting the Company’s achievements in 2023 along with the progress it has made during that time working toward its near- and long-term environmental, social and governance (ESG) objectives. This press release features multimedia. View the full release here: Headshot of Mike Jardon, Chief Executive Officer of Expro. (Photo: Business Wire) Projects delivered this year, that are highlighted in the report, include a custom solution to support the testing of ne...
Standard BioTools Announces Multi-Year Strategic Engagement with Brist...
Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced that it has entered into a multi-year engagement with global biopharmaceutical company Bristol Myers Squibb for use of the SomaScan® Platform as a tool for clinical trials in multiple therapeutic areas through 2026. The SomaScan P...
Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virt...
Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference THE WOODLANDS, Texas, April 03, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced Jeff Wade, Lexicon’s president and chief financial officer, Tom Garner, Lexicon’s senior vice president and chief commercial officer, and Craig Granowitz, M.D., Ph.D., Lexicon’s senior vice president and chief medical officer, will participate in a moderated discussion at the 23rd Annual Needham Virtual Healthcare conference Wednesday April 10th, 1:30-2:10pm. A simultaneous webcast will be available in the...
Capital Southwest Receives Affirmed Investment Grade Rating from Moody...
Capital Southwest Receives Affirmed Investment Grade Rating from Moody’s Investors Service Moody’s affirms Baa3 long-term issuer rating with a stable outlook DALLAS, April 02, 2024 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (“Capital Southwest,” or the “Company”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, today announced that Moody’s Investors Service, Inc. (“Moody’s”) has affirmed Capital Southwest’s investment grade long-term issuer ratin...
Moody's affirms Capital Southwest Corporation's Baa3 senior unsecured ...
Moody's Ratings (Moody's) has affirmed the Baa3 long-term issuer rating and senior unsecured debt rating of Capital Southwest Corporation (CSWC) and maintained the stable outlook. RATINGS RATIONALE CSWC's Baa3 senior unsecured debt rating reflects the company's strong capitalization, first-lien ...
Capital Southwest Receives Affirmed Investment Grade Rating from Fitch...
Capital Southwest Receives Affirmed Investment Grade Rating from Fitch Ratings Fitch affirms BBB- long-term issuer rating with a stable outlook DALLAS, March 27, 2024 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (“Capital Southwest”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, today announced that Fitch Ratings, Inc. (“Fitch”) has affirmed Capital Southwest’s investment grade long-term issuer rating of BBB- with a stable outlook. Factors cit...
Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attac...
Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo THE WOODLANDS, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced that four data presentations related to sotagliflozin, an inhibitor of two sodium glucose transport proteins (SGLT2 and SGLT1), will be delivered during the American College of Cardiology 73rd Annual Scientific Session & Expo being held April 6 - 8, 2024 in Atlanta, Georgia, including results from a post-hoc ...
Capital Southwest Announces New $150 MM Secured Credit Facility
Capital Southwest Announces New $150 MM Secured Credit Facility DALLAS, March 20, 2024 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (“Capital Southwest” or “we”") (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, announced today that its wholly owned subsidiary, Capital Southwest SPV LLC (the “SPV”), entered into a senior secured revolving credit facility (the “SPV Facility”) with Deutsche Bank AG, New York Branch. The SPV Facility provides for $150 mi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.